A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)

Ambulatory Blood Pressure Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00565006
• Other study ID #: 0859-012
• Secondary ID: 2007_656
• Status: Completed
• Phase: Phase 1
• First received: November 27, 2007
• Last updated: February 25, 2015
• Start date: July 2006
• Est. completion date: September 2006

Study information

• Verified date: February 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: September 2006
• Est. primary completion date: September 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 45 Years to 75 Years

Eligibility

Inclusion Criteria:

• You are between the ages of 45-75

• You are a man or non-pregnant woman

• You agree to not eat or drink fruit or fruit juices (orange, apple or grapefruit) for 2 weeks before starting study medication

Exclusion Criteria:

• You have smoked or used other nicotine-containing products (chewing tobacco) within the last 6 months

• You have used St. John's Wort or any products that include it within the last 2 weeks

• You have used herbal, organic, dietary or nutritional remedies within the last 2 weeks

• You have a history of drug allergies (anaphylaxis, angioedema)

• You have taken an investigational drug in another clinical trial within the last 4 weeks

• You have a history of cardiovascular disease including hypertension (high blood pressure)

• You have a history of renal disease

• You have a history of gall bladder disease or have had abnormal liver function tests

• You have a history of drug or alcohol abuse

• You drink more than 6 cups of caffeinated beverages a day (coffee, tea or cola)

Study Design

N/A

Related Conditions & MeSH terms

• Ambulatory Blood Pressure

Intervention

Drug:
• MK0859

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.